cghs

CGHS GLP-1 Guidelines 2026 showing Mounjaro and Semaglutide coverage for a limited group of eligible CGHS beneficiaries under the new government policy.

CGHS GLP-1 Guidelines 2026 – Mounjaro and Semaglutide Now Covered, But Only for a Narrow Group of Beneficiaries

—
August 3, 2026

The CGHS GLP-1 Guidelines 2026 mark the first time the Central Government Health Scheme (CGHS) has agreed to cover Injection Tirzepatide (Mounjaro) and Injection Semaglutide....